Ignite Creation Date:
2025-12-24 @ 2:38 PM
Ignite Modification Date:
2026-01-29 @ 8:07 PM
Study NCT ID:
NCT00373659
Status:
COMPLETED
Last Update Posted:
2012-06-13
First Post:
2006-09-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD
Sponsor:
University of Miami
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neovascular Age-related Macular Degeneration | View |